Dr Benjamin G Diven, MD | |
Corner Of Stewart And Breland, Student Health Center, Box 30001 Msc 3529, Las Cruces, NM 88003 | |
(505) 646-8308 | |
(505) 646-6428 |
Full Name | Dr Benjamin G Diven |
---|---|
Gender | Male |
Speciality | General Practice |
Location | Corner Of Stewart And Breland, Las Cruces, New Mexico |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1538276142 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208D00000X | General Practice | 8234 (New Mexico) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Benjamin G Diven, MD Corner Of Stewart And Breland, Student Health Center, Box 30001 Msc 3529, Las Cruces, NM 88003 Ph: (505) 646-8308 | Dr Benjamin G Diven, MD Corner Of Stewart And Breland, Student Health Center, Box 30001 Msc 3529, Las Cruces, NM 88003 Ph: (505) 646-8308 |
News Archive
"Almost every nation, regardless of its wealth and resources, faces a continuing shortage of nurses and an acute lack of nursing faculty available to educate more nurses. This dearth of practicing nurses and nurse educators is particularly critical in countries like Haiti and other developing high-risk, low-resourced nations," Martha Hill, dean of Johns Hopkins School of Nursing, writes in a Baltimore Sun opinion piece encouraging the expansion of global nursing.
Roche announced today that new 5 year follow-up data from two pivotal studies with Herceptin(R) (trastuzumab) in early breast cancer; key results from a study of Avastin(R) (bevacizumab) in the second-line treatment of advanced breast cancer and strong data on the use of trastuzumab-DM1 (T-DM1), the first antibody-drug conjugate in development for very advanced HER2-positive breast cancer, will all be presented during the CTRC-AACR San Antonio Breast Cancer Symposium (SABCS) from 9 to 13 December 2009.
The Food and Drug Administration (FDA) has approved Merit Medical Systems, Inc.'s phase 3 clinical trial protocol to treat primary liver cancer with QuadraSphereâ„¢ Microspheres (hqTACE) for delivery of doxorubicin. The clinical trial will involve U.S. and international interventional radiologists who treat patients with localized, unresectable hepatocellular carcinoma (HCC), the most common form of liver cancer.
A recent study in Behaviour & Information Technology investigated the role Facebook use plays in the creation or maintenance of social capital among 800 students from 7 universities in South Africa. Empirical research has linked social capital to many positives in society, such as improved mental and physical health and economic well-being.
› Verified 9 days ago
Dr Justin Lanier Sanders, D.O. General Practice Medicare: Accepting Medicare Assignments Practice Location: 4311 E Lohman Ave, Las Cruces, NM 88011 Phone: 575-566-7600 | |
Kevin J Allen, MD General Practice Medicare: Not Enrolled in Medicare Practice Location: 2465 S Telshor Blvd, Las Cruces, NM 88011 Phone: 505-440-9939 | |
Dr. Ramon A Saavedra, M.D. General Practice Medicare: May Accept Medicare Assignments Practice Location: 2930 Hillrise Dr, Ste 1, Las Cruces, NM 88011 Phone: 575-522-4040 Fax: 575-647-8381 | |
Miss Anne Firey Turbett, MD General Practice Medicare: Not Enrolled in Medicare Practice Location: Corner Of Stewart And Breland, Las Cruces, NM 88003 Phone: 505-646-1512 Fax: 505-646-6428 | |
Dr. Manuel Pavia Tan, M.D. General Practice Medicare: Not Enrolled in Medicare Practice Location: 4351 E Lohman Ave, Ste 301, Las Cruces, NM 88011 Phone: 575-532-8900 Fax: 575-532-8910 | |
Dr. Nicholas Nillo, M.D. General Practice Medicare: Not Enrolled in Medicare Practice Location: 307 Sanchez Pl, Las Cruces, NM 88005 Phone: 575-541-9376 |